News | March 07, 2011

Third-Generation Bare-Metal Coronary Stent Launched in Europe

March 8, 2011 – A third-generation bare-metal stent system has received the CE Mark in Europe. Boston Scientific’s Omega platinum chromium coronary stent system is intended to provide interventional cardiologists with improved acute performance in treating patients with coronary artery disease.

"In my experience, the platinum chromium alloy and design used in the Omega Stent offer excellent deliverability, visibility and conformability while improving radial strength and reducing stent recoil," said Antonio Colombo, M.D., director of the cardiac catheterization laboratory at Columbus Hospital and San Raffaele Hospital in Milan, Italy. "The Omega Stent and platinum chromium alloy offer meaningful performance improvements without the tradeoffs associated with older stent alloys."

The stent is part of the company’s PtCr Stent series, which includes the Taxus Element paclitaxel-eluting stent system and Promus Element everolimus-eluting stent system. All three stents feature the PtCr alloy and stent design, which combine to offer greater radial strength and flexibility while reducing stent recoil. The higher density alloy provides superior visibility while permitting thinner struts compared to prior-generation stents. The enhanced delivery system features a dual-layer balloon and is engineered to improve access to challenging lesions.

"The Omega Stent complements the PtCr Stent series, and gives interventional cardiologists the option to treat patients with a paclitaxel, everolimus or bare-metal stent," said Keith D. Dawkins, M.D., senior vice president and chief marketing officer for Boston Scientific’s cardiology, rhythm and vascular group.

The stent is offered in 48 sizes, ranging in diameter from 2.25 mm to 4.5 mm and lengths of 8 mm to 32 mm.

For more information: www.bostonscientific.com

Related Content

Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal| February 15, 2017
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug...
Biotronik Astron stent
Technology | Stents Peripheral| December 31, 2015
December 31, 2015 - The U.S.
Technology | Stents Bare Metal| December 09, 2015
Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the launch of the...
News | Antiplatelet and Anticoagulation Therapies| June 11, 2015
Patients who received a bare metal coronary stent did not display significant differences in rates of adverse events...
Technology | July 22, 2014
July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel...
Boston Scientific Rebel Platinum Chromium Coronary Stent System Bare Metal
News | March 13, 2014
Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the company's latest...
Biosensors BioMatrix

The LEADERS Trial showed that the Biosensors BioMatrix, a drug-eluting stent with a biodegradable abluminal polymer coating, was functionally equivalent to a regular nonbiodegradable stent.

Feature | February 04, 2013 | Kamran Zamanian, Ph.D.
The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents,...
News | December 27, 2012
December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United...
Overlay Init